Search results
Results from the WOW.Com Content Network
Medications for gastroparesis aim to manage symptoms and may include what are called prokinetic agents. These work by inducing stomach contractions to move food through your digestive tract.
It is frequently caused by autonomic neuropathy, occurring in about 30–50% of people with long-standing type 1 or type 2 diabetes. [4] In fact, diabetes mellitus has been named as the most common known cause of gastroparesis, as high levels of blood glucose may effect chemical changes in the nerves. [24]
This condition is also called rapid gastric emptying. [1] It is mostly associated with conditions following gastric or esophageal surgery, though it can also arise secondary to diabetes or to the use of certain medications; it is caused by an absent or insufficiently functioning pyloric sphincter , the valve between the stomach and the duodenum.
The condition can be caused by underlying medical issues, and one of the more common causes of gastroparesis is diabetes, according to the American College of Gastroenterology. It can also result ...
Gastric inhibitory polypeptide (GIP), also known as glucose-dependent insulinotropic polypeptide, is an inhibiting hormone of the secretin family of hormones. [5] While it is a weak inhibitor of gastric acid secretion, its main role, being an incretin , is to stimulate insulin secretion.
Gastric inhibitory polypeptide, also called glucose-dependent insulinotropic polypeptide, is a 42-amino acid polypeptide synthesized by K cells of the duodenum and small intestine. It was originally identified as an activity in gut extracts that inhibited gastric acid secretion and gastrin release, but subsequently was demonstrated to stimulate ...
Repaglinide is a medication used in addition to diet and exercise for blood sugar control in type 2 diabetes. [1] The mechanism of action of repaglinide involves promoting insulin release from β-islet cells of the pancreas; like other antidiabetic drugs, a main side effect concern is hypoglycemia. [1]
First-pass metabolism may occur in the liver (for propranolol, lidocaine, clomethiazole, and nitroglycerin) or in the gut (for benzylpenicillin and insulin). [4] The four primary systems that affect the first pass effect of a drug are the enzymes of the gastrointestinal lumen, [5] gastrointestinal wall enzymes, [6] [7] [8] bacterial enzymes [5] and hepatic enzymes.